Our findings are consistent with prior researchreporting increased IL-6 levels in both lesional skin and systemic circulation of psoriatic patients [5].Furthermore, IL-6 has been associated with the development of comorbidities such as insulin resistance and cardiovascular dysfunction inthese patients, making it a potential marker for both cutaneous and systemic disease burden [6,7]. This evidence concerns the gene IL6 and Insulin resistance.